Gulf sub-group analysis of the real-world Orion study
Prof. Mohamed Hassanein, consultant Endocrinologist, Dubai hospital, Chair of DAR international alliance, presenting safety and effectiveness of insulin glargine 300 U/ml in participants with T2DM who fast during Ramadan in Gulf region.
![KOL_Diabetes_&_Ramadan_Talk3_(1)](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-kw/new/science/image-(78).jpg/jcr:content/image%20(78).jpg)
KOL_Diabetes_&_Ramadan_Talk3_(1)
Related articles
MAT-BH-2200398/V1/April2022